---
title: "BeOne Medicines Chief Executive Officer Sold Shares Worth Over $980K"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290248393.md"
description: "BeOne Medicines CEO John Oyler sold American Depositary Shares worth $980,686 on June 16, 2026. The sales were executed to satisfy mandatory tax withholding provisions related to the vesting of restricted share units. Following the transaction, Oyler holds 5,649,640 ordinary shares directly and 46,031,994 indirectly."
datetime: "2026-06-18T21:20:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290248393.md)
  - [en](https://longbridge.com/en/news/290248393.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290248393.md)
generator: "portal-rs"
---

# BeOne Medicines Chief Executive Officer Sold Shares Worth Over $980K

John Oyler, a reporting person and Chief Executive Officer, sold American Depositary Shares at weighted average prices of $264.8738, $265.9856 and $266.6947 per ADS in three transactions on June 16, 2026. The total proceeds from the sales were $980,686. Following the reported transactions, the reporting person directly owns 5,649,640 ordinary shares and no longer directly owns American Depositary Shares, and indirectly owns 46,031,994 ordinary shares. The sales were effected pursuant to a mandatory tax withholding provision in the reporting person's restricted share unit award agreement in connection with the vesting of a previously granted restricted share unit award.

Reporter Name

Oyler John

Relationship

Chief Executive Officer

Type

Sell

Amount

$980,686

SEC Filing

Form 4

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [BGNE.US](https://longbridge.com/en/quote/BGNE.US.md)
- [06160.HK](https://longbridge.com/en/quote/06160.HK.md)
- [ONC.US](https://longbridge.com/en/quote/ONC.US.md)
- [688235.CN](https://longbridge.com/en/quote/688235.CN.md)

## Related News & Research

- [BeOne Medicines Announces Voluntary Agreement with U.S. Government to Expand Access to Innovative Cancer Medicines | ONC Stock News](https://longbridge.com/en/news/297552849.md)
- [CLSA: China Biotech Fundamentals Remain Solid; Top Picks BEONE MEDICINES , INNOVENT BIO  and LEADS BIOLABS-B](https://longbridge.com/en/news/297994035.md)
- [How Investors Are Reacting To BeOne Medicines (ONC) First-Line HER2-Positive GEA Immunotherapy Approval](https://longbridge.com/en/news/297146976.md)
- [BeOne Medicines to Present at the Morgan Stanley Annual Global Healthcare Conference | ONC Stock News](https://longbridge.com/en/news/297636674.md)
- [As AI money floods the market, San Francisco renters weigh buyouts](https://longbridge.com/en/news/297419586.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**